查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1919252

一次性胃肠管市场按产品类型、材质、应用、最终用户和销售管道划分－2026-2032年全球预测

Disposable Gastrointestinal Tube Market by Product Type, Material, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年一次性胃肠管市场价值为 7.8346 亿美元，预计到 2026 年将成长至 8.2427 亿美元，年复合成长率为 7.68%，到 2032 年将达到 13.1573 亿美元。

关键市场统计数据
基准年 2025 7.8346亿美元
预计年份：2026年 8.2427亿美元
预测年份 2032 13.1573亿美元
复合年增长率 (%) 7.68%

全面介绍一次性胃肠管领域，整合临床需求、材料技术创新和不断变化的医疗服务重点。

一次性胃肠管市场正处于不断发展的临床通讯协定、材料科学创新和医疗服务模式变革的交汇点。近年来，临床医生和采购主管都将患者舒适度、感染预防和精简供应链放在首位，迫使製造商重新思考其产品设计和分销策略。门诊手术的增加、居家医疗服务的扩展以及对早期经肠营养的日益重视，都提升了一次性餵食和引流装置在所有医疗机构中的重要性。

临床分散化、监管要求和材料创新正在共同重塑产业的产品蓝图和商业模式。

临床实务、监管重点和商业行为等多种因素的共同作用，正促使医疗产业经历变革性转变。临床上，门诊手术和短期住院治疗的趋势日益明显，这推动了对可在多种环境下轻鬆使用并支持安全过渡到居家照护的设备的需求。这种转变有利于那些安装简单、减轻非专业看护者训练负担、并能与床边影像和远端监测系统相容的设备设计。

2025年关税调整对整个价值链的采购、生产地点和筹资策略的累积影响

2025年的关税调整提升了在美国营运或出口到美国的企业在供应链规划和采购方面灵活性的重要性。关税变化影响了筹资策略，促使製造商重新评估零件原产地风险，并在条件允许的情况下加速生产区域化。依赖单一国家采购的企业面临更高的到岸成本，迫使它们寻找替代供应商、建立双重采购安排，或将製造地转移到关税优惠的地区。

深度細項分析揭示了产品、材料、应用、最终用户和销售管道方面的差异，从而确定临床相关性和商业策略。

细分市场层面的趋势分析揭示了临床需求、成本限制和产品差异化之间的交集，为製造商和采购商提供了策略优先排序指南。依产品类型划分，市场细分包括内视镜导管、胃造瘻管、空肠导管和鼻胃管。胃造瘻管进一步经皮为经皮内视镜胃造瘻术 (PEG) 和放射引导下胃造瘻术 (RIG) 两种类型，而鼻胃管则进一步细分为 Lewin 管和 Salem 引流管两种亚型。每种产品组都有其独特的临床工作流程和性能要求。内视镜导管需要精准性和可视性，而胃造瘻管则需要在长期舒适性和牢固固定之间取得平衡。空肠导管产品优先考虑远端解剖结构的放置稳定性，而鼻胃管则需要在吸引效率和防止误吸之间进行权衡。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和差异化应用驱动因素正在塑造商业和监管策略。

区域趋势受美洲、欧洲、中东和非洲以及亚太地区医疗服务模式、法规结构和供应链结构差异的影响。在美洲，采购能力的提升以及大型医疗系统间联合采购协议的普及，推动了对标准化产品的需求，并有助于降低整体医疗成本。此外，门诊和居家照护模式的快速普及，也提升了支持病患安全转诊和缩短住院时间的耗材的重要性。

在竞争激烈的市场环境中，大型製造商、专业OEM厂商和敏捷型Start-Ups都在寻求透过合作、高品质投资和全通路销售策略来实现差异化。

竞争格局由众多医疗设备製造商、专业OEM厂商、契约製造以及专注于导管、连接器和插入辅助工具的新兴新Start-Ups组成。现有企业利用规模经济、成熟的分销网络和深厚的临床关係来维持与主要医院客户的市场份额。同时，灵活的专业公司和Start-Ups往往透过特定的改进措施来获得市场认可，例如提高患者舒适度、增强插入安全性以及提供可降低感染风险的一次性使用功能。

为经营团队提供实用建议，以确保在不同的医疗保健环境中实现临床偏好、营运韧性和商业性差异化。

产业领导者应采取平衡策略，结合产品差异化、供应链韧性和积极的监管应对，以赢得临床青睐并保障利润率。应优先开发能够直接解决临床难题的产品特性，例如非侵入性针尖、提高渗透性和连接器标准化，并透过有针对性的临床证据和上市后调查计画检验这些特性。同时，应加大材料研发投入，优化柔软性、生物相容性和环境影响之间的平衡，并在监管允许的情况下考虑开展可回收或环保一次性产品的试验计画。

采用透明严谨的研究途径，整合关键相关人员访谈、监管审查和三角验证的二手分析，以支持可操作的研究结果。

本研究采用质性与量性结合的调查方法，以确保在保障资料保密性和完整性的同时，获得切实可行的洞见。主要研究工作包括对医院系统、门诊手术中心、诊所和居家医疗机构的临床医生、采购主管和供应链经理进行结构化访谈，以收集有关临床需求、采购行为和通路偏好的第一手资讯。这些访谈以及与製造商、契约製造製造商和经销商的对话，用于了解生产限制、前置作业时间动态和定价策略。

简洁的结论整合了临床需求、供应链实际状况和策略要务，这些要素共同定义了该领域的竞争优势。

总而言之，在临床分散化、监管力度加大、材料创新和采购惯例变革的共同影响下，一次性胃肠道器材市场持续发展演变。改进器械设计以优化临床工作流程和提升病患舒适度变得日益重要，而材料选择和供应链设计则决定了临床性能和成本效益之间的平衡。关税趋势和区域贸易考虑凸显了采购柔软性、尽可能近岸外包以及整个分销网路合约透明度的重要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 一次性胃肠管市场（依产品类型划分）

  • 内视镜管
  • 胃造瘻管
    • 经皮视镜胃造瘻术
    • 放射导下置入的胃造瘻管
  • 空肠管
  • 鼻胃管
    • 莱文管
    • 塞勒姆集水管

9. 一次性胃肠管市场（依材料划分）

  • 聚氨酯
  • PVC
    • 医用级
    • 标准级
  • 硅酮

第十章 按应用分類的一次性胃肠管市场

  • 减压
  • 引流
    • 胆汁引流
    • 胰臟引流
  • 管饲

第十一章 以最终用户分類的一次性胃肠管市场

  • 门诊手术中心
  • 诊所
  • 居家医疗
  • 医院
    • 大学医院
    • 社区医院

第十二章 一次性胃肠管市场（依销售管道划分）

  • 批发商销售
    • 增值转售商
    • 批发商
  • 医院采购
  • 线上销售

13. 各地区一次性胃肠管市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 一次性胃肠管市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国一次性胃肠管市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国一次性胃肠管市场

第十七章：中国一次性胃肠管市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CareU Medical Co., Ltd
  • CONMED Corporation
  • Cook Medical, LLC
  • ICU Medical, Inc.
  • Medtronic plc
  • Olympus Corporation
  • Pacific Hospital Supply Co., Ltd
  • Teleflex Incorporated
  • Well Lead Medical Co., Ltd
Product Code: MRR-F14BA1B34168

The Disposable Gastrointestinal Tube Market was valued at USD 783.46 million in 2025 and is projected to grow to USD 824.27 million in 2026, with a CAGR of 7.68%, reaching USD 1,315.73 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 783.46 million
Estimated Year [2026] USD 824.27 million
Forecast Year [2032] USD 1,315.73 million
CAGR (%) 7.68%

An integrative introduction to the disposable gastrointestinal tube environment combining clinical needs, material breakthroughs, and evolving care delivery priorities

The disposable gastrointestinal tube landscape sits at the intersection of evolving clinical protocols, material science innovation, and shifting care delivery models. In recent years clinicians and procurement leaders have concurrently prioritized patient comfort, infection prevention, and streamlined supply chains, prompting manufacturers to rethink product design and distribution strategies. Increasing outpatient procedures, expansion of home healthcare services, and greater emphasis on early enteral feeding have elevated the profile of single-use feeding and drainage devices across care settings.

As the clinical community seeks devices that minimize complications and that integrate more easily into workflows, innovation has focused on softer polymers, atraumatic tips, and enhanced radiopacity. These design enhancements aim to reduce insertion trauma, improve placement confidence, and lower the need for repeat procedures. At the same time, materials selection-ranging from polyurethane to silicone and differentiated grades of PVC-continues to shape performance trade-offs between flexibility, biocompatibility, and cost.

Supply chain pressures, regulatory scrutiny of single-use device waste, and the growing role of digital procurement platforms all influence how manufacturers position disposable gastrointestinal tubes. Stakeholders across hospitals, ambulatory surgical centers, clinics, and home healthcare providers are evaluating product portfolios against clinical outcomes, total cost of care, and environmental considerations. As a result, the current environment rewards pragmatic innovation that aligns patient-centric benefits with procurement efficiencies and regulatory compliance.

How clinical decentralization, regulatory imperatives, and materials innovation are jointly reshaping product roadmaps and commercial models in the industry

The industry is experiencing transformative shifts driven by converging forces in clinical practice, regulatory emphasis, and commercial behavior. Clinically, there is a clear trajectory toward outpatient procedures and shorter hospital stays, which in turn increases demand for devices that are easy to use across multiple settings and that support safe transitions to home care. This shift favors designs that simplify placement, reduce training burden for non-specialist caregivers, and support compatibility with bedside imaging and remote monitoring systems.

Regulatory change is another pivotal driver. Authorities are emphasizing not only device safety and traceability but also lifecycle considerations related to single-use medical materials. This has pushed manufacturers to invest in traceability features, standardized labeling, and more robust post-market surveillance infrastructure. Additionally, procurement channels are diversifying: hospitals are increasingly procuring through group purchasing frameworks while smaller facilities and home health providers are adopting online platforms and supplier-managed inventory models. These changes create both opportunity and risk for companies that can rapidly adapt commercial models.

On the innovation front, materials science and manufacturing advances have lowered the barrier to producing differentiated tubing profiles with integrated connectors and enhanced radiopacity. At the same time, sustainability conversations are catalyzing research into recyclable components and alternative disposal pathways. Collectively, these transformative shifts are reshaping product roadmaps, partnerships, and investment priorities across the value chain.

The cumulative impact of tariff recalibrations in 2025 on sourcing, production footprints, and procurement strategies across the value chain

The introduction of tariff adjustments in 2025 has amplified the importance of supply chain planning and procurement agility for companies operating in or exporting to the United States. Tariff changes have influenced sourcing strategies, encouraging manufacturers to reassess origin-of-component risk and to accelerate regionalization of production where feasible. Firms that had relied on single-country sourcing faced increased landed costs and were prompted to seek alternative suppliers, dual-sourcing arrangements, or to shift manufacturing footprints to tariff-favored jurisdictions.

In response to these cost pressures, many organizations prioritized cost-to-serve analyses and began negotiating longer-term fixed-price agreements with key suppliers to stabilize input costs. Companies with flexible production capacity leveraged contract manufacturing partners to mitigate capital expenditure while maintaining responsiveness to demand fluctuations. At the distribution layer, import duties influenced order consolidation strategies and inventory staging, with several stakeholders increasing onshore buffer inventories to insulate clinical operations from near-term cost volatility.

Tariff-driven recalibrations also accelerated conversations about vertical integration and nearshoring. For some manufacturers, moving certain assembly or packaging steps closer to end markets immediately reduced tariff exposures and shortened lead times. From a procurement standpoint, hospital systems and group purchasers used the tariff context to press suppliers for greater pricing transparency and to include tariff pass-through clauses in supply contracts. Altogether, the cumulative tariff environment in 2025 incentivized resilience, transparency, and flexibility across the value chain.

Deep segmentation intelligence revealing product, material, application, end-user, and sales channel distinctions that determine clinical fit and commercial strategy

Segment-level dynamics reveal where clinical demand, cost constraints, and product differentiation intersect, guiding strategic prioritization for manufacturers and purchasers alike. Product type segmentation spans Endoscopy Tube, Gastrostomy Tube, Jejunal Tube, and Nasogastric Tube, with the Gastrostomy Tube further distinguished by Percutaneous Endoscopic Gastrostomy and Radiologically Inserted Gastrostomy variants, and the Nasogastric Tube further divided into Levin Tube and Salem Sump Tube subtypes. Each product family presents distinct clinical workflows and performance expectations: endoscopy tubes require precision and visibility, gastrostomy options must balance long-term comfort and secure anchoring, jejunal products prioritize placement stability in distal anatomy, and nasogastric variants trade off suction efficiency and aspiration protection.

Material considerations materially affect both clinical performance and procurement decisions. Materials such as Polyurethane, PVC, and Silicone offer different profiles of flexibility, biocompatibility, and cost. Within PVC, a further split between Medical Grade and Standard Grade highlights regulatory and clinical preferences for certain use cases. Applications are differentiated across decompression, drainage, and feeding, with drainage subcategories of Biliary Drainage and Pancreatic Drainage that demand specialized luminal designs and compatibility with interventional workflows.

End users include Ambulatory Surgical Centers, Clinics, Home Healthcare providers, and Hospitals, where hospitals can be further categorized into Academic Medical Centers and Community Hospitals. These distinctions matter because purchasing behavior, clinical protocols, and product requirements diverge across care settings. Sales channels likewise influence commercialization strategies: Distributor Sales comprised of both Value-Added Resellers and Wholesalers, Hospital Purchases conducted through procurement departments and group purchasing frameworks, and Online Sales targeting smaller facilities and home care networks. Understanding how each segmentation axis intersects with clinical and operational priorities enables companies to tailor value propositions, pricing approaches, and service offerings to the highest-return segments.

Regional dynamics and differentiated adoption drivers across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape commercial and regulatory strategy

Regional dynamics are shaped by differing care delivery models, regulatory frameworks, and supply chain architectures across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, procurement sophistication among large health systems and the widespread adoption of group purchasing arrangements drive demand for standardized product families and total-cost-of-care justifications. This region also sees rapid adoption of outpatient and home-based care pathways, increasing emphasis on disposables that support safe patient transitions and reduce inpatient dwell time.

Across Europe, Middle East & Africa, regulatory harmonization efforts in parts of Europe coexist with complex reimbursement landscapes in national systems, which leads to patchwork adoption curves for novel disposable devices. Healthcare providers in these regions often balance price sensitivity with strong clinical governance, pushing manufacturers to demonstrate clear clinical benefits and compliance with regional medical device standards. The Asia-Pacific region exhibits a dual dynamic of rapid hospital infrastructure expansion in some markets and a rising private-sector outpatient network in others. Local manufacturing capability and regional trade agreements play a central role in pricing and supply reliability, while clinical training programs and adoption of minimally invasive procedures support demand for higher-specification disposable tubes.

Across these regions, differential investments in clinical training, digital procurement platforms, and waste management infrastructure influence product acceptance and procurement cycles. Manufacturers that align product portfolios and commercial approaches with the region-specific incentives and constraints stand to gain traction faster than those that apply a one-size-fits-all strategy.

How leading manufacturers, specialized OEMs, and agile startups are competing through partnerships, quality investments, and omnichannel commercialization to drive differentiation

Competitive landscapes are populated by a mix of diversified medical device manufacturers, specialized OEMs, contract manufacturers, and emerging startups that bring focused innovations to tubing materials, connectors, and insertion aids. Incumbent players leverage scale, established distribution networks, and deep clinical relationships to maintain share in core hospital accounts, while nimble specialists and startups often capture attention through targeted improvements in patient comfort, insertion safety, and disposability features that reduce infection risk.

Strategic behavior among companies includes portfolio rationalization to concentrate on high-margin differentiated products, strategic partnerships with contract manufacturing organizations to manage capital intensity, and licensing or co-development arrangements with digital health firms to integrate procedural guidance and traceability. Investment priorities increasingly emphasize regulatory readiness, quality systems that support global registrations, and evidence-generation programs that demonstrate clinical outcomes such as reduced complication rates and improved feeding efficiency.

On the commercial front, leading organizations are refining omnichannel go-to-market models that blend hospital contract sales with distributor partnerships for smaller facilities and direct-to-consumer or clinician-facing online channels for home healthcare. Mergers and acquisitions continue to serve as a mechanism to acquire complementary technologies and to expand geographically, while manufacturing collaborations and service-level agreements with logistics providers are being used to mitigate supply chain risk and improve time-to-clinic responsiveness.

Actionable recommendations for executives to secure clinical preference, operational resilience, and commercial differentiation across diverse care settings

Industry leaders should adopt a balanced strategy that combines product differentiation, supply chain resilience, and proactive regulatory engagement to capture clinical preference while protecting margins. Prioritize development of product features that directly address clinician pain points-such as atraumatic tips, improved radiopacity, and connector standardization-while validating those features through targeted clinical evidence and post-market surveillance programs. Simultaneously, invest in materials R&D to optimize the trade-offs between flexibility, biocompatibility, and environmental footprint, and consider pilot programs for recyclable or lower-impact disposables where regulatory pathways permit.

On the operational side, diversify supplier bases and evaluate regional manufacturing options to reduce exposure to tariff volatility and to shorten lead times to major demand centers. Strengthen contractual terms with logistics and distribution partners to include contingency clauses and inventory-as-a-service models that improve on-shelf availability for high-use accounts. Commercially, deploy differentiated pricing and service bundles matched to end-user segments: for instance, tailor offerings for ambulatory surgical centers and home healthcare with simplified packaging and clinician training modules, while delivering full-service solutions for academic medical centers that require clinical evidence and integrated support.

Finally, accelerate adoption of digital tools across sales, training, and after-sales support to reduce adoption friction and to capture real-world performance data. Collaborate with clinical champions and payer stakeholders to build the value story that aligns device performance with reduced complications and improved care transitions. These combined moves will help leaders capture both clinical preference and procurement dollars while mitigating operational risk.

A transparent and rigorous research approach integrating primary stakeholder interviews, regulatory review, and triangulated secondary analysis to underpin actionable insights

The research methodology combines qualitative and quantitative approaches to ensure robust, actionable insights while preserving confidentiality and data integrity. Primary research included structured interviews with clinicians, procurement leaders, and supply chain managers across hospital systems, ambulatory surgical centers, clinics, and home healthcare providers to capture first-hand perspectives on clinical needs, purchasing behavior, and channel preferences. These interviews were supplemented by conversations with manufacturers, contract manufacturers, and distributors to understand production constraints, lead-time dynamics, and pricing strategies.

Secondary research involved systematic review of regulatory guidance, device standards, clinical literature related to enteral feeding and drainage devices, and publicly available procurement documentation to contextualize clinical practice patterns and compliance requirements. Data triangulation techniques were applied to reconcile differing inputs and to validate observed trends. Segmentation analysis leveraged product, material, application, end-user, and sales channel taxonomies to surface differentiated adoption vectors and to inform scenario development for commercial planning.

Quality assurance protocols included cross-validation of interview findings against procurement datasets and supply chain indicators, iterative review with industry subject-matter experts, and checks for consistency with known regulatory timelines and public clinical guidance. Confidentiality safeguards protected proprietary commercial information shared during primary research, and analytical assumptions were documented to enable transparent interpretation of the insights and recommended actions.

A concise conclusion synthesizing clinical imperatives, supply chain realities, and strategic imperatives that define competitive advantage in the sector

In summary, the disposable gastrointestinal tube space is evolving under the combined influence of clinical decentralization, regulatory scrutiny, material innovation, and shifting procurement practices. Device design enhancements that address clinician workflow and patient comfort are increasingly essential, while material selection and supply chain design determine the balance between clinical performance and cost-efficiency. Tariff dynamics and regional trade considerations have emphasized the importance of sourcing flexibility, nearshoring where viable, and contractual transparency across the distribution network.

Segmentation clarity-across product variants such as endoscopy, gastrostomy, jejunal, and nasogastric types; materials including polyurethane, PVC, and silicone; applications from decompression to targeted drainage and feeding; and end users ranging from ambulatory centers to academic hospitals-enables companies to prioritize investments and tailor go-to-market approaches. Region-specific strategies must reflect differences in procurement behavior, regulatory expectations, and infrastructure maturity. Competitive advantage will accrue to organizations that pair pragmatic innovation with robust quality systems, flexible manufacturing footprints, and omnichannel commercial models that meet end users where they operate.

Leaders who act now to align product development, evidence generation, and supply chain resilience will be better positioned to address clinical needs, manage cost pressures, and capture durable clinical preference in a rapidly changing care delivery environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Disposable Gastrointestinal Tube Market, by Product Type

  • 8.1. Endoscopy Tube
  • 8.2. Gastrostomy Tube
    • 8.2.1. Percutaneous Endoscopic Gastrostomy
    • 8.2.2. Radiologically Inserted Gastrostomy
  • 8.3. Jejunal Tube
  • 8.4. Nasogastric Tube
    • 8.4.1. Levin Tube
    • 8.4.2. Salem Sump Tube

9. Disposable Gastrointestinal Tube Market, by Material

  • 9.1. Polyurethane
  • 9.2. PVC
    • 9.2.1. Medical Grade
    • 9.2.2. Standard Grade
  • 9.3. Silicone

10. Disposable Gastrointestinal Tube Market, by Application

  • 10.1. Decompression
  • 10.2. Drainage
    • 10.2.1. Biliary Drainage
    • 10.2.2. Pancreatic Drainage
  • 10.3. Feeding

11. Disposable Gastrointestinal Tube Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Home Healthcare
  • 11.4. Hospitals
    • 11.4.1. Academic Medical Centers
    • 11.4.2. Community Hospitals

12. Disposable Gastrointestinal Tube Market, by Sales Channel

  • 12.1. Distributor Sales
    • 12.1.1. Value-Added Resellers
    • 12.1.2. Wholesalers
  • 12.2. Hospital Purchases
  • 12.3. Online Sales

13. Disposable Gastrointestinal Tube Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Disposable Gastrointestinal Tube Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Disposable Gastrointestinal Tube Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Disposable Gastrointestinal Tube Market

17. China Disposable Gastrointestinal Tube Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. Braun Melsungen AG
  • 18.6. Becton, Dickinson and Company
  • 18.7. Boston Scientific Corporation
  • 18.8. Cardinal Health, Inc.
  • 18.9. CareU Medical Co., Ltd
  • 18.10. CONMED Corporation
  • 18.11. Cook Medical, LLC
  • 18.12. ICU Medical, Inc.
  • 18.13. Medtronic plc
  • 18.14. Olympus Corporation
  • 18.15. Pacific Hospital Supply Co., Ltd
  • 18.16. Teleflex Incorporated
  • 18.17. Well Lead Medical Co., Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY ENDOSCOPY TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY ENDOSCOPY TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY ENDOSCOPY TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PERCUTANEOUS ENDOSCOPIC GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY RADIOLOGICALLY INSERTED GASTROSTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY JEJUNAL TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY JEJUNAL TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY JEJUNAL TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY LEVIN TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY LEVIN TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY LEVIN TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALEM SUMP TUBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALEM SUMP TUBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALEM SUMP TUBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MEDICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MEDICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MEDICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY STANDARD GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY STANDARD GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY STANDARD GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DECOMPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DECOMPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DECOMPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY BILIARY DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY BILIARY DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY BILIARY DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PANCREATIC DRAINAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PANCREATIC DRAINAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PANCREATIC DRAINAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY FEEDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY FEEDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY FEEDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY VALUE-ADDED RESELLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY VALUE-ADDED RESELLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY VALUE-ADDED RESELLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY WHOLESALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY WHOLESALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY WHOLESALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITAL PURCHASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITAL PURCHASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITAL PURCHASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 210. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 215. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 216. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. GCC DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 246. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 249. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 250. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 252. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 254. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. G7 DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 258. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 261. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 262. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 263. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 264. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 266. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 268. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. NATO DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY GASTROSTOMY TUBE, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY NASOGASTRIC TUBE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY PVC, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DRAINAGE, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA DISPOSABLE GASTROINTESTINAL TUBE MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)